SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-23-030544
Filing Date
2023-06-20
Accepted
2023-06-20 17:21:20
Documents
2
Period of Report
2023-06-16

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 5305
2 EXHIBIT 24 brhc20054639_ex24.htm EX-24 10344
  Complete submission text file 0001140361-23-030544.txt   16966
Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Issuer) CIK: 0001781174 (see all company filings)

IRS No.: 825125532 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACRIVON THERAPEUTICS, INC. 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address
Holm-Jorgensen Rasmus (Reporting) CIK: 0001950496 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41551 | Film No.: 231026424